Healthcare
The FDA Is Adopting California’s Failed Policies on Tobacco
The FDA's proposal to ban menthol-flavored tobacco will put consumers at risk with illicit products.
Taxpayer Tricks and Treats for Halloween 2023
CAGW's 24th annual compilation of its hair-raising, harrowing, and horrifying Taxpayer Tricks and Treats is a scary read.
Biden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
Citizens Against Government Waste Releases $4 Trillion in Prime Waste-Cutting Recommendations
Total savings from Prime Cuts 2023 are $402.3 billion in the first year and $4 trillion over five years.
The War on Tobacco Harm Reduction Products Will Continue to Fail
Banning tobacco harm reduction products put consumers at risk with illicit products.
Citizens Against Government Waste Releases Issue Brief on the Benefits of Tobacco Harm Reduction Products
CAGW's new issue brief details the benefits of tobacco harm reduction products.
The 340B Drug Discount Program Needs an Overhaul
CAGW has long been concerned with the misuse of the 340B Program.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
FDA Flavor Bans Create a Dangerous Black Market
The FDA must now attempt to fix the mess it has created by banning flavored tobacco products.
Council for Citizens Against Government Waste Launches Campaign Against Government-Run Healthcare
CCAGW has fought for decades to stop government-run healthcare and promote patient choice and control.
Biden's Budget and the SMART Prices Act Will Devastate Drug Development
Pharmaceutical price controls in President Biden's budget and the SMART Choices Act will devastate drug development.
New Study Exposes More Exploitation and Waste in the 340B Drug Discount Program
A new study, “The 340B Drug Discount Program Exceeds $100B in 2022,” shows the program is misused.
